← Evidence map

ArticleGene therapy2013

Modulating vascular intimal hyperplasia using HSV-1 mutant requires activated MEK.

C L Skelly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2013
2014
2015
2016
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 22418062